Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Paravertebral block (PVB) is a regional anesthesia technique being evaluated by Spectrum Health Hospitals (now Corewell Health West) for the management of acute postoperative pain in patients undergoing mastectomy. In this specific clinical trial context, the procedure involves the injection of 20-30 mL of 0.5% ropivacaine into the thoracic paravertebral space, typically at the T1-T5 levels. Ropivacaine is a long-acting amide-type local anesthetic that works by reversibly blocking sodium channels in nerve fibers, thereby preventing the transmission of pain signals from the surgical site to the central nervous system. This technique is being compared against pectoral nerve blocks (PECs) to determine its efficacy in reducing systemic opioid consumption and improving recovery outcomes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on paravertebral block-Spectrum Health Hospitals-postoperative pain.